Norfem

Quick links to important sections

Norfem

Method of action: Endocrine Therapy

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norfem

Property Description
Active Ingredients Ethinyl Estradiol, Norgestrel
Form Oral Tablet
Pharmacological Class Combined Oral Contraceptive (COC), Estrogens/Progestins
Primary Use Prevention of Pregnancy (Contraception)
Origin Synthetic

What Type of Medicine is Norfem?

Norfem is a pharmaceutical designated as a Combined Oral Contraceptive (COC), which requires a prescription for use. It is systematically administered as an oral tablet and falls under the high-level Hormonal Contraceptive pharmacological class, specifically categorized as an Estrogens/Progestins combination. This classification is fundamental, indicating the medication utilizes the combined action of two different hormone types to regulate the reproductive system. Combined oral contraceptives are an established method of preventing pregnancy. Norfem is recognized as a specific monophasic oral tablet, meaning the dose of its active ingredients remains constant throughout the active pill cycle.


Composition and Origin: Synthetic Estrogen and Progestin

Norfem is a combination product containing two synthesized active ingredients: Ethinyl Estradiol and Norgestrel. Ethinyl Estradiol is a highly potent, synthesized form of estrogen, while Norgestrel is a specific synthetic progestin. Since both core constituents are laboratory-engineered compounds designed to mimic and regulate the body's natural hormones, the drug is characterized by its synthetic origin. The consistent and precise delivery of these synthetic hormones through the tablet allows for stable, reliable hormonal regulation necessary for effective fertility management. Fixed-dose combinations of Ethinyl Estradiol and Norgestrel provide reliable contraception.


What is the General Purpose of Norfem?

The established and exclusive purpose of Norfem is the reliable prevention of pregnancy in women of reproductive potential. This primary therapeutic goal is achieved through an integrated physiological approach where the combined hormones initiate multiple layers of protection. Norfem is typically used by women seeking a simple, daily, hormonal regimen for consistent birth control. By providing hormonal signals that suppress the natural cycle and alter the reproductive tract environment, Norfem offers a highly effective and foundational method for contraception, which is its sole general purpose.

Regulatory References

  1. NIH: Oral Contraceptive Pills

What side effects are possible with Norfem?

Possible Side Effects and Safety Information

The safety profile for Norfem, a Combined Oral Contraceptive, is structured around frequency-classified adverse reactions and specific, officially documented serious risks. Regulatory documents categorize many effects by the physiological system involved, with reactions commonly occurring in the Gastrointestinal, Nervous System, and Reproductive System.

Adverse Reactions and Frequency

Adverse reactions officially classified as Common include nausea, headache or migraine, breast tenderness, and spotting or breakthrough bleeding. Unscheduled bleeding and spotting are noted in regulatory information as being most frequent during the first three months of use. Weight gain and mood changes are also commonly reported effects.

Serious Safety Considerations

The most significant, though Rare, serious adverse reactions documented in regulatory labeling relate to the vascular system. These include the risk of Venous Thromboembolism (VTE), such as deep vein thrombosis (DVT) and pulmonary embolism, and Arterial Thrombotic Events, including stroke and myocardial infarction. Official safety notes indicate this risk is highest during the first year of use.

Other serious safety concerns include the documented risk of developing Hypertension and the rare association with Hepatic Neoplasia (benign and malignant liver tumors).

Population-Specific Restrictions

Official prescribing information defines specific safety constraints on use. The medication is strictly contraindicated in women over 35 years of age who smoke, due to a significantly increased risk of serious cardiovascular events. Contraindications also apply to individuals with a history of thromboembolic disorders, severe liver disease, or certain hormone-sensitive cancers, reflecting the drug's inherent systemic and hormonal impact.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Norfem (Ethinyl Estradiol and Norgestrel) is defined by its documented manifestations and mandated emergency actions. No specific antidote is known for an overdose of this combined oral contraceptive, and management focuses on symptomatic and supportive treatment.

Documented Manifestations and Severity

Scope Official Regulatory Statement
Common Presentations The most frequently reported signs following ingestion of an excess dose include Nausea, Vomiting, Headache, Drowsiness, Breast tenderness, and Vaginal bleeding (withdrawal bleeding).
Severity Classification Overdose is generally documented as not likely to be life-threatening.
Specific Note Accidental ingestion by young children has been reported, with resulting manifestations typically being mild and transient.

Emergency Actions and Required Care

Following any suspected overdose, individuals must seek immediate medical attention or call a national poison control center. Urgent medical care is explicitly required if severe symptoms develop. These severe signs, which mandate immediate intervention, include manifestations suggestive of Thromboembolic events (such as sudden chest pain or unexplained swelling in a limb) or indications of Liver problems (such as jaundice). The requirement for urgent medical help is triggered by these life-threatening outcomes, not solely by the ingestion of the excess dose.

Therapeutic Uses of Norfem

What Norfem treats: main uses and benefits

Norfem is a combined oral contraceptive used primarily for the prevention of pregnancy. It contains two types of hormones: a progestogen and an estrogen. Beyond its primary function in reproductive health, the medication is often used to manage specific hormonal and menstrual symptoms.

Primary Indication

The principal use of Norfem is to provide reliable, reversible contraception. It works through several mechanisms to prevent conception, including the inhibition of ovulation, thickening of the cervical mucus to impede sperm motility, and altering the uterine lining.

Additional Therapeutic Benefits

In addition to preventing pregnancy, Norfem is frequently utilized for the following clinical purposes:

  • Regulation of the Menstrual Cycle: It helps establish a regular withdrawal bleed for individuals with irregular cycles.
  • Management of Dysmenorrhea: The medication is effective in reducing the severity of menstrual cramps and associated pain.
  • Reduction of Menstrual Blood Loss: It is often used to treat heavy menstrual bleeding (menorrhagia), which can help prevent iron deficiency anemia.
  • Improvement of Acne: Due to its hormonal effects, it may be used to treat moderate acne in individuals who also require contraception.
  • Premenstrual Syndrome (PMS): Some users experience a reduction in the physical and emotional symptoms associated with the premenstrual phase of the cycle.
  • Endometriosis Support: It may be used to manage pelvic pain associated with endometriosis by suppressing the cyclic growth of the endometrial lining.

Long-term Health Considerations

Clinical observations indicate that the use of combined oral contraceptives like Norfem may be associated with a reduced long-term risk of developing certain conditions, such as ovarian and endometrial cancers, as well as functional ovarian cysts.

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Norfem

Regulatory documents define strict eligibility criteria for the use of Norfem, a Combined Oral Contraceptive ( COC) containing Ethinyl Estradiol and Norgestrel. These rules primarily focus on pre-existing cardiovascular and hormone-sensitive conditions.

Eligibility Classification Status/Population
Populations Allowed Females of reproductive potential who lack formal contraindications; post-pubertal adolescents (post-menarche).
Populations Contraindicated Women over 35 years old who smoke.
History of blood clots ( DVT, PE, stroke, MI) or migraine with aura.
Known breast cancer or other hormone-sensitive malignancy.
Active liver disease (e.g., severe cirrhosis) or liver tumors (benign or malignant).
Uncontrolled hypertension or diabetes mellitus with vascular disease.
Age-Related Rules Use is contraindicated before menarche and not indicated for post-menopausal women (geriatric use).
Pregnancy/Lactation Status Contraindicated during pregnancy. Not recommended during breastfeeding.

Eligibility-related restrictions also require discontinuation at least four weeks before and two weeks after major surgery or prolonged immobilization due to elevated risk of thromboembolism. Use in women with well-controlled hypertension requires routine blood pressure monitoring. These regulations define the patient pool for whom the medicine's use is officially permitted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Norfem (Ethinyl Estradiol/Norgestrel) has officially documented interaction patterns primarily involving pharmacokinetic alterations and changes in plasma protein binding as described in regulatory documents.

Formal Interaction-Related Restrictions

Co-administration with specific drug regimens for Hepatitis C Virus (HCV) infection, such as those containing Ombitasvir/Paritaprevir/Ritonavir, with or without Dasabuvir, is formally contraindicated due to the documented risk of significant liver enzyme elevations.

Interaction Type Interacting Substances (Examples) Official Outcome Description
Metabolic Clearance Interference Anticonvulsants (e.g., Phenytoin), Rifampin, St John's wort Reduced serum concentrations of the contraceptive hormones (Enzyme Inducers).
Hormone Binding Effects Thyroid Hormone Replacement, Corticosteroids Increased dosage requirement for co-administered replacement therapies.
Absorption Interference Colesevelam Requires a separation of administration interval to mitigate reduced hormone absorption.

Substances classified as strong enzyme inhibitors (e.g., certain Azole antifungals) are documented to cause an increase in the plasma concentrations of Norfem's hormones. Additionally, the regulatory profile advises against co-consumption of Grapefruit Juice, which may increase hormone exposure by interfering with metabolism. Exposure to other co-administered drugs, such as Lamotrigine, is documented to be decreased when taken concurrently with this combined oral contraceptive.

Mechanism of Action

Norfem contains norethindrone, a synthetic progestin that functions as an agonist of the progesterone receptor (PR). This binding occurs in target cells within the hypothalamus, pituitary gland, and reproductive tract. Once formed, the drug-receptor complex translocates to the cell nucleus where it interacts with specific Hormone Response Elements (HREs) on the DNA, modulating the transcription rate of various genes.

This molecular action initiates a cascade across the hypothalamic-pituitary-ovarian (HPO) axis. Norethindrone provides negative feedback, resulting in the suppression of pulsatile Gonadotropin-Releasing Hormone (GnRH) release from the hypothalamus. The subsequent decrease in the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary prevents the final maturation and ensuing ovulation of an ovarian follicle.

Concurrently, the drug induces decidualization and atrophy of the endometrium, reducing cellular proliferation, and causes the cervical mucus to become thicker and less permeable, impeding sperm motility.

Dosage and Administration Information

Norfem is an oral tablet administered daily according to a fixed 28-day regimen. The standard dosage involves taking one tablet by mouth once every day, without regard to meals. The correct administration schedule requires sequential use of the blister pack, beginning a new pack immediately after the last tablet of the previous one.

Administration Schedule and Timing

Norfem use follows a 21/7 cyclic pattern. The 28-day cycle consists of 21 consecutive days where the active, hormone-containing tablets (e.g., 0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol) are taken, followed by 7 days where the inactive (placebo) tablets are taken, or an interval where no tablets are taken. To maintain consistent hormone levels, the tablet must be taken at the same time each day.

Regimen initiation offers two main protocols: the Day 1 Start (beginning on the first day of menses) or the Sunday Start (beginning on the first Sunday after menses starts). For the Sunday Start, an additional non-hormonal barrier method must be used during the first 7 consecutive days of tablet administration.

Missed Dose and Specific Populations

Specific rules govern missed doses: if one active tablet is missed, it should be taken as soon as remembered. If multiple doses are missed, specific actions are directed that may include using a backup non-hormonal barrier method for a 7-day period. For patient populations, Norfem is indicated for post-menarcheal females but is not indicated for women of advanced age. Initiation of the regimen postpartum should not occur earlier than four weeks after delivery for women who are not breastfeeding.

Recent Clinical Evidence

Research on Compound X

Several clinical trials have evaluated the compound in a research context to examine its potential role in pain and inflammation management. A large Phase III study reported that a portion of study participants, specifically 80%, recorded a reduction in pain scores. In the study, the observed onset of action occurred in some participants within 30 minutes, which indicates it was one option that has been studied for acute pain. Research also reviewed participant experience during the trials.


Combination Therapy Research

Research into using Compound X alongside Physiotherapy (PT) has been the focus of multiple studies. These investigations evaluated whether this combination reduced pain and whether it affected joint mobility in comparison to PT alone. Studies explored the outcomes for patients with chronic arthritis who combined Compound X with PT for the observed outcomes. The combination was observed to result in certain specific outcomes, and findings suggested a potential additive effect.


Cautions and Future Directions

Research was conducted under strict inclusion criteria, which limited participation for individuals with specific pre-existing health issues. This included studies that excluded patients with certain pre-existing conditions, such as kidney disease. Research is now examining whether the compound has an effect on the prevention of migraines, but this research area falls outside of the initially approved scope of the compound for now. Further research is ongoing to evaluate the outcomes of long-term use.

Key Studies & References

  1. Phase III Trial of Compound X for Acute Pain: Efficacy, Safety, and Onset of Action

Frequently Asked Questions (FAQ)

Common questions about Norfem (FAQ)

Q: How quickly does Norfem start working?

A: According to the official product information, the contraceptive effect is typically described as requiring at least 7 consecutive days of active tablet use in the first cycle. For certain start protocols, the regulatory information indicates that a non-hormonal barrier method must be used during this initial 7-day period.

Q: How long does the effect of Norfem last after taking it?

A: Studies and official information indicate that the drug is designed to be fully reversible. Ovulation and the return of a typical menstrual cycle usually occur shortly after the last active tablet is taken. Regulatory data confirms that the medication is not associated with an adverse impact on long-term fertility.

Q: Is it common for people to misunderstand how Norfem is supposed to be used?

A: The 28-day regimen consists of two types of tablets: 21 active tablets containing the hormones and 7 inactive (placebo) tablets, which contain no medicine. The inactive tablets are included to help maintain the daily dosing routine, a distinction that is important for maintaining the correct regimen.

Q: Does Norfem have any known interactions with herbal supplements?

A: Official warnings specifically name certain herbal products, such as St. John's wort, as substances that may interfere with the hormone levels of combined oral contraceptives, potentially reducing their effectiveness. The importance of disclosing all supplements to a healthcare provider is noted in official documentation.

Q: What kind of monitoring is usually needed when taking Norfem?

A: Regulatory documents advise that for women taking this medication, blood pressure should be monitored at routine visits. Additionally, women with pre-existing conditions like diabetes or dyslipidemia (abnormal cholesterol levels) may require careful monitoring of those specific conditions.

Q: Is Norfem used for more than just one condition?

A: In addition to its established purpose for the prevention of pregnancy, official product information indicates that specific formulations of combined oral contraceptives are also approved for the treatment of moderate acne vulgaris in females who have achieved menarche and desire oral contraception.

Q: Will Norfem make me feel sleepy or tired?

A: Regulatory sources list fatigue and a general lack of energy as potential reported side effects. Adverse reaction listings note that effects such as fatigue may impact the ability to operate machinery.

Q: Are there any food or drinks I should avoid while using Norfem?

A: Regulatory profiles specifically advise against the co-consumption of Grapefruit Juice. This is because it may interfere with the drug's metabolism and cause an increase in the exposure to the hormones contained in the tablet.

Q: Is Norfem a narcotic or controlled substance?

A: The medication is classified as a Combined Oral Contraceptive. Regulatory classification indicates that the drug is not designated as a narcotic or a controlled substance under the U.S. Controlled Substances Act.

Q: How do I know if the Norfem I have is expired?

A: The expiration date is required to be printed on the product packaging. Regulatory guidelines state that any expired or unused medication must be disposed of according to established guidelines, which typically involves consulting established regulatory guidelines.

Q: Can I take Norfem if I have high blood pressure?

A: Official eligibility guidelines state that the medication is contraindicated in women with uncontrolled hypertension. For women with blood pressure that is well-controlled, regulatory documents advise that blood pressure be monitored carefully during routine visits.

Q: What happens if I stop taking Norfem suddenly?

A: Because the medication works by suppressing ovulation (the release of an egg), the regulatory profile indicates that ovulation can return quickly after discontinuation. Therefore, the possibility of pregnancy can exist as soon as the next menstrual cycle.

Q: Does Norfem affect mood or anxiety levels?

A: Regulatory documents list mood changes and depression as potential adverse reactions. Official labeling also advises careful observation of women with a history of depression. The effect on anxiety specifically is not typically highlighted as a common adverse event.

Q: Do older adults require special consideration when using Norfem?

A: The official prescribing information states that this medication is not indicated for use in post-menopausal (geriatric) women. Furthermore, specific contraindications apply to women over 35 years of age who smoke, due to an increased risk of serious cardiovascular events.

Q: Is Norfem known to cause allergic reactions?

A: While general allergic reactions are not listed among the most common adverse effects, regulatory warnings indicate that immediate medical attention is necessary if signs of a severe allergic reaction occur. These signs include hives, difficult breathing, or swelling of the face, lips, tongue, or throat.

Q: Are there different strengths or versions of Norfem?

A: As a combined oral contraceptive, the drug may be available in different strengths (dosages of the active ingredients) or different tablet sequences. This includes monophasic versions (where the dose stays the same) versus triphasic versions, which are all defined in the official labeling.

Q: Can Norfem be taken with vitamins or minerals?

A: Official warnings note the importance of informing a healthcare provider about all concomitant medicines, including vitamins and minerals, to ensure there are no unintended effects or interactions.

Q: Why does the packaging list so many potential side effects?

A: The full list of potential side effects in regulatory documents includes all adverse events that were reported in clinical trials, regardless of whether the event was ultimately found to be caused by the drug. Regulatory bodies require the documentation of all risks, even those that occur very rarely.

Q: Are there any restrictions on driving while using Norfem?

A: Certain reported side effects, such as dizziness and blurred vision, may affect a person's ability to operate machinery. The official label suggests that understanding the medication’s effect on the individual is necessary before undertaking tasks like driving.

Q: How does Norfem influence a person's regular hormone levels?

A: The medication primarily works by suppressing the body's natural pulsatile release of key hormones—Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH)—which are necessary for ovulation. The hormones in the pill provide the necessary hormonal signaling for contraception during the treatment cycle.

Q: What is the risk of dependence or addiction with Norfem?

A: The drug is not classified as a controlled substance and official regulatory documents confirm that it is not associated with a risk of dependence or addiction.

Q: Does research indicate long-term risks with Norfem use?

A: Regulatory documents discuss that studies have shown a rare, increased risk of developing hepatocellular carcinoma (a type of liver tumor) in women who have used combined oral contraceptives for extended periods, sometimes defined as more than 8 years of use.

Q: What does the research say about Norfem's overall effectiveness?

A: Clinical data cited in regulatory information reports that when combined oral contraceptives are taken correctly and consistently, official information reflects that they represent an effective method for preventing pregnancy.

Q: Is there a generic version of Norfem available?

A: The compound (Ethinyl Estradiol/Norgestrel) is generally available as a generic medication. These generic versions typically contain the same active ingredients and are officially approved to be bioequivalent to the branded product.

Q: Can men use Norfem for any reason?

A: The drug is specifically indicated in regulatory documents for use by females of reproductive potential to prevent pregnancy and/or for the treatment of moderate acne. It has no official indication for use in men.

Q: What is the 'How it works' description for Norfem in simple terms?

A: In simple terms, the hormones in the tablet work primarily to prevent the release of an egg (ovulation) each month. They also change the cervical mucus to help block sperm and alter the uterine lining to prevent implantation.

How should Norfem be stored and disposed of?

How to Store and Dispose of Norfem (Ethinyl Estradiol/Norgestrel)

Norfem must be stored at controlled room temperature, typically between 20°C and 25°C. The tablets must be kept in the original, tightly closed container and protected from excessive heat, moisture, and direct light. It is a regulatory requirement to keep the product out of the reach and sight of children and to keep the medicine from freezing.

Disposal

Expired or unused Norfem must be disposed of according to official regulatory guidelines. Patients should consult a healthcare professional for guidance on disposal. The preferred method is utilizing an authorized medicine take-back program. Tablets should not be flushed down the toilet or poured into a drain unless explicitly instructed by a government authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norfem found in:

A-Z Index: